Ovarian carcinoma tumor-initiating cells have a mesenchymal phenotype. - Wikidata - wikimedia - TriplyDB

Ovarian carcinoma tumor-initiating cells have a mesenchymal phenotype.

Ovarian carcinoma tumor-initiating cells have a mesenchymal phenotype.

http://www.wikidata.org/entity/Q47834312

about

Regulation of ovarian cancer stem cells or tumor-initiating cells YAP/TEAD co-activator regulated pluripotency and chemoresistance in ovarian cancer initiated cells Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer.Novel population of small tumour-initiating stem cells in the ovaries of women with borderline ovarian cancer Targeting the Wnt/β-catenin pathway in primary ovarian cancer with the porcupine inhibitor WNT974.MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis.A multi-stage process including transient polyploidization and EMT precedes the emergence of chemoresistent ovarian carcinoma cells with a dedifferentiated and pro-inflammatory secretory phenotype Small putative NANOG, SOX2, and SSEA-4-positive stem cells resembling very small embryonic-like stem cells in sections of ovarian tissue in patients with ovarian cancer The RUNX1 transcription factor is expressed in serous epithelial ovarian carcinoma and contributes to cell proliferation, migration and invasion.Selenium-enriched polysaccharides from Pyracantha fortuneana (Se-PFPs) inhibit the growth and invasive potential of ovarian cancer cells through inhibiting β-catenin signaling.Patient-derived ovarian cancer xenografts re-growing after a cisplatinum treatment are less responsive to a second drug re-challenge: a new experimental setting to study response to therapy.Ovarian cancer stem cells: still an elusive entity?ALDH enzymatic activity and CD133 positivity and response to chemotherapy in ovarian cancer patients.Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer.High-frequency irreversible electroporation targets resilient tumor-initiating cells in ovarian cancer.Ovarian Cancers: Genetic Abnormalities, Tumor Heterogeneity and Progression, Clonal Evolution and Cancer Stem Cells.

P2860

Q26853096-55849860-D3D0-4B16-9F45-BB71B51B3767 Q28250934-882B659D-65A4-4F51-BFD8-BA00A2E923BB Q30275354-06EDA47C-4AC9-4E7F-B774-4ECA8331E0D3 Q30818695-F5E26EA4-C9F1-484B-9709-386814B07621 Q34504817-E3CA2F51-68C8-4855-8192-2FA9342D368C Q36381924-66E59678-C112-48EF-B023-0265B3C20733 Q36545528-DAB06C19-0D8E-4FCB-8DB0-169280BCE6A4 Q36651828-5EB7E620-8D8C-4297-B50C-CA5FF5C9F504 Q36798094-1B6EE64D-6215-427F-BEFC-C083B59375A9 Q37317553-C9794EA2-21AB-49CB-8B82-D8F6B4FD6B0F Q37702541-F12E1DDA-7C31-43EB-9CD2-5AAB458D55D8 Q37713683-B33A2DAC-1CAA-4BAB-8B99-94D1730D356C Q39779683-8E792F22-875C-497A-B2F7-63957368F156 Q42317503-0A2A2BE7-2969-4DDF-A61C-74E00FAE7679 Q45074250-B8D89B8F-0173-441E-A741-11FB2626337A Q48124146-39CFCD0C-8FEA-404C-A10C-2D7FE8BC02BC

P2860

Ovarian carcinoma tumor-initiating cells have a mesenchymal phenotype.

http://www.wikidata.org/entity/Q47834312

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Ovarian carcinoma tumor-initiating cells have a mesenchymal phenotype.

@en

Ovarian carcinoma tumor-initiating cells have a mesenchymal phenotype.

@nl

type

label

Ovarian carcinoma tumor-initiating cells have a mesenchymal phenotype.

@en

Ovarian carcinoma tumor-initiating cells have a mesenchymal phenotype.

@nl

prefLabel

Ovarian carcinoma tumor-initiating cells have a mesenchymal phenotype.

@en

Ovarian carcinoma tumor-initiating cells have a mesenchymal phenotype.

@nl

P1433

Q47834312-CA356507-6345-47CB-B086-07FEFE6CE137

P1476

Q47834312-7A253C2A-6B9A-4306-ACB2-2BED387B5AFD

P2093

Q47834312-222C28A8-B753-4EB2-A504-3E38935B03A2

Q47834312-36AA75D5-6F59-4437-8BAA-19CFE6065990

Q47834312-4E3CC9A0-2A04-49E5-A6B2-FA2F52B2DA06

Q47834312-68952A3A-88CA-4CE6-AEC4-821C25B4E8B6

Q47834312-8DDCED7F-FA07-46A3-8C89-46C83471F9FE

Q47834312-A3AD2C6E-520A-4B9B-BD87-3D83AA5BE708

Q47834312-BFF2FC51-2692-4B25-BADD-01E2B5AB4A0C

P2860

Q47834312-02B2A939-40A1-480F-83AD-3BECA6E008DE

Q47834312-0DC2BCA5-7ACF-4C9D-BA1A-C5736533C09E

Q47834312-0F7E6A5D-3E42-4332-80CC-BF2A440C5F86

Q47834312-1DC87FBA-0BB0-4130-BDC1-8EE4007D3598

Q47834312-23242AAE-E34D-44BE-90FB-D8E361D59621

Q47834312-2348DF3B-16A3-419E-800A-4B3D8AF01F53

Q47834312-27B2A9E4-3244-422A-9FC1-049676F5CE2C

Q47834312-3761C22B-B962-4EA1-AC91-9008EFD1600F

Q47834312-3B450E26-DC42-4D21-B85F-665FDC03EB15

Q47834312-550F36FC-02D8-4C11-973C-1F1152D0C859

P304

Q47834312-49661A8A-345F-4908-A507-67E814C521BA

P31

Q47834312-BBE5E079-348B-4DD9-BD7A-79E041E23458

P356

Q47834312-E44FB446-F11A-4E59-953F-AD474F0FA174

P433

Q47834312-6ADA3BF6-C68E-48B6-830A-C2CD9EEC05D6

P478

Q47834312-D89199B3-8CF0-4563-8318-8DD4A9415569

P50

Q47834312-2A126188-A00C-4CCD-ABF7-D28FD5AD95AC

Q47834312-3A4A6B14-DA83-476E-9F1E-D5554DE2EF34

Q47834312-96E4E883-BB83-436E-AB07-3A3806791416

Q47834312-D606E20D-3D35-4E0F-8CF2-1CD1436CD686

P577

Q47834312-A68426DC-C873-4259-A569-DA5D0249FAE2

P5875

Q47834312-3DBC443A-8022-4DAC-A491-D1DBB5265AC3

P698

Q47834312-7BD18924-C951-45FE-AA2D-36815005B6C2

P356

P1433

P1476

Ovarian carcinoma tumor-initiating cells have a mesenchymal phenotype.

@en

P2093

Costantino Mangioni

http://www.w3.org/2001/XMLSchema#string

Francesca Bono

http://www.w3.org/2001/XMLSchema#string

Giorgio Russo

http://www.w3.org/2001/XMLSchema#string

Giovanna Damia

http://www.w3.org/2001/XMLSchema#string

Mario Signorelli

http://www.w3.org/2001/XMLSchema#string

Patrizia Perego

http://www.w3.org/2001/XMLSchema#string

Sergio Bernasconi

http://www.w3.org/2001/XMLSchema#string

P2860

Identification and characterization of ovarian cancer-initiating cells from primary human tumors

The epithelial-mesenchymal transition generates cells with properties of stem cells

The basics of epithelial-mesenchymal transition

Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment

Prospective identification of tumorigenic breast cancer cells

Identification and expansion of the tumorigenic lung cancer stem cell population

Exploring the role of cancer stem cells in radioresistance

Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis

Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance

EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer

P304

1966-1976

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/CC.20308

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Monica Ganzinelli

Francesca Ricci

Massimo Broggini

P577

2012-05-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224867974

http://www.w3.org/2001/XMLSchema#string

P698

22544328

http://www.w3.org/2001/XMLSchema#string